New Advances in the Lung Cancer Continuum
New Advances in the Lung Cancer Continuum: From Lung Cancer Screening to Diagnosis and Treatment
Lung cancer remains the leading cause of death in the US. While the overall 5-year survival rate of lung cancer has improved to 21.7%, this survival rate improves to 59% when lung cancer is detected early. Unfortunately, only 23% of all lung cancers are detected early.
Join local lung health experts as they discuss the need to optimize lung cancer screening, diagnosis and treatment. This webinar will provide an update on lung cancer screening, including the new USPSTF lung cancer guidelines, define new technologies to diagnose lung cancer earlier and determine optimal strategies to guide lung nodule management.
Date: Wednesday, October 6th
What’s New: Lung cancer screening, the latest diagnostic biomarkers and robotic bronchoscopy
Minimally Invasive Thoracoscopic Surgery for Lung Cancer: VATS to Robotic Surgery
Lung Cancer Therapy: Optimizing Outcomes
Q & A
Please reach out to Erik Maranto at EventsCHI@Lung.org with any questions.